A Comprehensive Clinical Genetics Approach to Critical Congenital Heart Disease in Infancy - 20/11/20
, Benjamin J. Landis, MD 2, 3, Ashley Parrott, MS, LGC 4, Erin M. Miller, MS, LGC 1, 5, Alyxis Coyan, MS, LGC 6, Lauren Walters, PhD 7, Robert B. Hinton, MD 1, 5, Paula Goldenberg, MD, MSW, MSCE 8, 9, Stephanie M. Ware, MD, PhD 2, 3Abstract |
Objective |
To investigate the frequency of genetic diagnoses among infants with critical congenital heart disease (CHD) using a comprehensive cardiovascular genetics approach and to identify genotype–phenotype correlations.
Study design |
A retrospective chart review of patients evaluated by cardiovascular genetics in a pediatric cardiac intensive care unit from 2010 to 2015 was performed. Infants with CHD who were <1 month of age were included. CHD was classified using structured phenotype definitions. Cardiac and noncardiac phenotypes were tested for associations with abnormal genetic testing using χ1 and Fisher exact tests.
Results |
Genetic evaluation was completed in 293 infants with CHD, of whom 213 had isolated congenital heart disease (iCHD) and 80 had multiple congenital anomalies. Overall, the yield of abnormal genetic testing was 26%. The multiple congenital anomalies cohort had a greater yield of genetic testing (39%) than the iCHD cohort (20%) (OR 2.7). Using a non-hierarchical CHD classification and excluding 22q11.2 deletion and common aneuploidies, right ventricular obstructive defects were associated with abnormal genetic testing (P = .0005). Extracardiac features associated with abnormal genetic testing included ear, nose, and throat (P = .003) and brain (P = .0001) abnormalities. A diagnosis of small for gestational age or intrauterine growth retardation also was associated with abnormal genetic testing (P = .0061), as was presence of dysmorphic features (P = .0033, OR 3.5). Infants without dysmorphia with iCHD or multiple congenital anomalies had similar frequencies of abnormal genetic testing.
Conclusions |
The present study provides evidence to support a comprehensive cardiovascular genetics approach in evaluating infants with critical CHD while also identifying important genotype–phenotype considerations.
Le texte complet de cet article est disponible en PDF.Keywords : chromosome microarray, copy number variant, genetic syndrome, genetic testing, cardiovascular genetics
Abbreviations : CCHMC, CHD, CICU, CNV, ENT, FISH, iCHD, IUGR, ROH, RVOTO, SGA, VSD, VUS
Plan
| The National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health funded the REDCap data management system used in this study. The authors declare no conflicts of interest. |
Vol 227
P. 231 - décembre 2020 Retour au numéro
Article précédent
- Delayed Development of Coronary Artery Aneurysm in Patients with Kawasaki Disease Who Were Clinically Responsive to Immunoglobulin
- Ryohei Matsuoka, Kenji Furuno, Etsuro Nanishi, Sagano Onoyama, Hazumu Nagata, Kenichiro Yamamura, Yuichiro Sugitani, Ayako Kuraoka, Yumi Mizuno, Koichi Sagawa, Satoshi Honjo, Toshiro Hara, Shouichi Ohga
- Relationships between Physiologic and Neuropsychologic Functioning after Fontan
- Kelly R. Wolfe, Deborah R. Liptzin, Dania Brigham, Sarah L. Kelly, Carey Rafferty, Megan Albertz, Adel K. Younoszai, Michael V. Di Maria
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?